Yefei Wang

1.2k total citations
51 papers, 897 citations indexed

About

Yefei Wang is a scholar working on Surgery, Ophthalmology and Molecular Biology. According to data from OpenAlex, Yefei Wang has authored 51 papers receiving a total of 897 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 10 papers in Ophthalmology and 9 papers in Molecular Biology. Recurrent topics in Yefei Wang's work include Vascular Malformations and Hemangiomas (5 papers), Mesenchymal stem cell research (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Yefei Wang is often cited by papers focused on Vascular Malformations and Hemangiomas (5 papers), Mesenchymal stem cell research (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Yefei Wang collaborates with scholars based in China, United States and Australia. Yefei Wang's co-authors include Xianqun Fan, Shengfang Ge, Huifang Zhou, Xiaoping Bi, Yixiong Zhou, Yue Sun, Peiquan Zhao, Li-Quan Zhao, Jibo Zhou and Huang Zhu and has published in prestigious journals such as ACS Nano, Biomaterials and Scientific Reports.

In The Last Decade

Yefei Wang

47 papers receiving 882 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yefei Wang China 14 286 239 229 208 112 51 897
Manisha Mehta United States 17 130 0.5× 162 0.7× 202 0.9× 156 0.8× 25 0.2× 30 831
David O. Zamora United States 22 178 0.6× 368 1.5× 175 0.8× 357 1.7× 57 0.5× 35 1.2k
Manuel Fischer Germany 18 74 0.3× 310 1.3× 206 0.9× 476 2.3× 37 0.3× 75 1.1k
Jong Bok Lee South Korea 20 189 0.7× 204 0.9× 81 0.4× 242 1.2× 58 0.5× 104 1.3k
Jane Ashworth United Kingdom 28 337 1.2× 712 3.0× 334 1.5× 630 3.0× 259 2.3× 87 2.2k
Zhenlong Zheng South Korea 21 96 0.3× 88 0.4× 106 0.5× 262 1.3× 83 0.7× 64 1.2k
Moloud Ahmadi United States 23 256 0.9× 492 2.1× 58 0.3× 378 1.8× 86 0.8× 33 1.5k
Albert Y. Cheung United States 21 111 0.4× 360 1.5× 732 3.2× 201 1.0× 125 1.1× 89 1.3k
Maxim Bez Israel 16 123 0.4× 61 0.3× 125 0.5× 179 0.9× 21 0.2× 31 777

Countries citing papers authored by Yefei Wang

Since Specialization
Citations

This map shows the geographic impact of Yefei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yefei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yefei Wang more than expected).

Fields of papers citing papers by Yefei Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yefei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yefei Wang. The network helps show where Yefei Wang may publish in the future.

Co-authorship network of co-authors of Yefei Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yefei Wang. A scholar is included among the top collaborators of Yefei Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yefei Wang. Yefei Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xiaoran, Tongxin Ge, Shaoyun Wang, et al.. (2025). Epigenetic reprogramming holds promise in enhancing anti-tumor efficacy of CAR T cell therapy. Biotechnology Advances. 83. 108649–108649.
2.
Ge, Shengfang, Ti‐Fei Yuan, Xianting Ding, et al.. (2025). Neurotransmitters in tumors: chemical cross-talk shaping tumor progression. Biomarker Research. 13(1). 125–125.
3.
Yang, Jie, et al.. (2024). Prognostic factors for lacrimal gland adenoid cystic carcinoma: a retrospective study in Chinese patients. International Journal of Ophthalmology. 17(8). 1423–1430. 1 indexed citations
4.
Zhu, Tianyu, Jiahao Shi, Ruobing Jia, et al.. (2023). MYC-targeted genes predict distant recurrence in patients with ocular adnexal extranodal marginal zone lymphoma. Annals of Hematology. 102(9). 2413–2423. 1 indexed citations
5.
Shi, Jiahao, Tianyu Zhu, Min Zhou, et al.. (2022). Predicting the risk of distant and local recurrence for patients with ocular adnexal extranodal marginal zone lymphoma: a matched case–control study. British Journal of Ophthalmology. 107(10). 1560–1566. 3 indexed citations
6.
Shi, Jiahao, Tianyu Zhu, Huimin Lin, et al.. (2022). Proteotranscriptomics of ocular adnexal B-cell lymphoma reveals an oncogenic role of alternative splicing and identifies a diagnostic marker. Journal of Experimental & Clinical Cancer Research. 41(1). 234–234. 7 indexed citations
7.
Fang, Li, Huifang Chen, Yefei Wang, et al.. (2021). Functional Studies of Novel FOXL2 Variants in Chinese Families With Blepharophimosis–Ptosis–Epicanthus Inversus Syndrome. Frontiers in Genetics. 12. 616112–616112. 8 indexed citations
8.
Li, Yongyun, Jie Yang, Yazhuo Huang, et al.. (2021). Cellular heterogeneity and immune microenvironment revealed by single-cell transcriptome in venous malformation and cavernous venous malformation. Journal of Molecular and Cellular Cardiology. 162. 130–143. 9 indexed citations
9.
Luo, Yingxiu, Huifang Chen, Shengfang Ge, et al.. (2021). Clinical and pathological risk factors for worse stage and mortality of eyelid and periocular squamous cell carcinoma. British Journal of Ophthalmology. 106(10). 1338–1343. 3 indexed citations
10.
Chai, Peiwei, Jie Yu, Yue Xing, et al.. (2020). LncRNA CANT1 suppresses retinoblastoma progression by repellinghistone methyltransferase in PI3Kγ promoter. Cell Death and Disease. 11(5). 306–306. 27 indexed citations
11.
Li, Yongyun, Yang Liu, Jie Yang, et al.. (2020). A novel variant in GPAA1, encoding a GPI transamidase complex protein, causes inherited vascular anomalies with various phenotypes. Human Genetics. 139(12). 1499–1511. 6 indexed citations
12.
Li, Yongyun, Peng Li, Zhi Yang, et al.. (2020). BMP9 attenuates occurrence of venous malformation by maintaining endothelial quiescence and strengthening vessel walls via SMAD1/5/ID1/α-SMA pathway. Journal of Molecular and Cellular Cardiology. 147. 92–107. 10 indexed citations
13.
Chai, Peiwei, Yingxiu Luo, Chuandi Zhou, et al.. (2019). Clinical characteristics and mutation Spectrum of NF1 in 12 Chinese families with orbital/periorbital plexiform Neurofibromatosis type 1. BMC Medical Genetics. 20(1). 158–158. 7 indexed citations
14.
Yang, Jie, Chuandi Zhou, Yefei Wang, Xianqun Fan, & Renbing Jia. (2019). Multimodal therapy in the management of lacrimal gland adenoid cystic carcinoma. BMC Ophthalmology. 19(1). 125–125. 20 indexed citations
15.
Wang, Zi, Qing Xie, Yu Zhang, et al.. (2015). A regulatory loop containing miR-26a, GSK3β and C/EBPα regulates the osteogenesis of human adipose-derived mesenchymal stem cells. Scientific Reports. 5(1). 15280–15280. 32 indexed citations
16.
Wang, Yefei, et al.. (2015). Serum BAFF and APRIL levels in patients with autoimmune hemolytic anemia and their clinical significance. International Journal of Hematology. 102(4). 394–400. 8 indexed citations
17.
Xie, Qing, Zi Wang, Huifang Zhou, et al.. (2015). The role of miR-135-modified adipose-derived mesenchymal stem cells in bone regeneration. Biomaterials. 75. 279–294. 93 indexed citations
18.
19.
Wang, Zhiliang, Renbing Jia, Shengfang Ge, et al.. (2011). Ocular Complications of Human Immunodeficiency Virus Infection in Eastern China. American Journal of Ophthalmology. 153(2). 363–369.e1. 13 indexed citations
20.
Fan, Jiayan, Yefei Wang, Bing Han, et al.. (2010). FOXL2 mutations in Chinese families with Blepharophimosis syndrome (BPES). Translational research. 157(1). 48–52. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manisha Mehta Breakdown of academic impact, for papers by David O. Zamora Breakdown of academic impact, for papers by Manuel Fischer Breakdown of academic impact, for papers by Jong Bok Lee Breakdown of academic impact, for papers by Jane Ashworth Breakdown of academic impact, for papers by Zhenlong Zheng Breakdown of academic impact, for papers by Moloud Ahmadi Breakdown of academic impact, for papers by Albert Y. Cheung Breakdown of academic impact, for papers by Maxim Bez
Rankless by CCL
2026